Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2019 16:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., Aug. 14, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
August 06, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS

LEXINGTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
July 30, 2019 16:01 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx®...
July 30, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the Canaccord Genuity Growth Conference

LEXINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for...
July 26, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies

LEXINGTON, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
July 24, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in...
July 03, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
June 28, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts

LEXINGTON, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, ranked...
June 20, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019

LEXINGTON, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in...
June 17, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Highlights Current and Future Opportunities for its Breakthrough Rapid Diagnostic Technology for Biothreat Pathogen Detection

Data on T2Candida auris research-use-only demonstrates 5-hour time-to-resultversus 14-days with blood culture T2MR Technology demonstrates high sensitivity for the detection of biothreat pathogens ...